COMMUNIQUÉS West-GlobeNewswire

Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
18/11/2025
IRVINE, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced preliminary results from an investigator-initiated trial conducted at the University of Chicago [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
18/11/2025
ZUG, Switzerland, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The attached notification relates to the purchase of ordinary shares by a member of the Company’s Board of Directors. Attachment notification-of-managers-transaction- [...]
Genmab Announces Pricing of Private Offering of Senior Secured Notes and Senior Unsecured Notes and Completion of Syndication of New Senior Secured Term Loan Facility
18/11/2025
Media Release COPENHAGEN, Denmark; November 18, 2025 Genmab A/S (Nasdaq: GMAB) (“Genmab”) announced today that it and its wholly owned subsidiary Genmab Finance LLC (“Genmab Finance”) have priced their previously [...]
argenx Announces Results of Extraordinary General Meeting of Shareholders
18/11/2025
November 18, 2025 – 10:01 PM C ET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
18/11/2025
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on November 15, 2025 it granted stock options to purchase 87,297 restricted stock units (RSUs [...]
Suja Life Announces Confidential Submission of Draft Registration Statement
18/11/2025
OCEANSIDE, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Suja Life, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
18/11/2025
Company Announcement COPENHAGEN, Denmark; November 18, 2025 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 32,059 shares as a consequence of the exercise of employee warrants. The increase is effected [...]
Rad Source Launches RS® 420 Q+ Boost & RS® 420 MAX – High-Capacity Cannabis Decontamination Solutions
18/11/2025
BUFORD, Ga., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Rad Source Technologies, Inc. (Rad Source ® ), the global leader in x-ray-based cannabis decontamination, proudly announces the launch of two advanced systems: RS ® 420 Q+ [...]
UPDATE – PrognomiQ Launches ProVue Lung, a Proteomics-Based Laboratory Developed Test to Aid in the Early Detection of Lung Cancer
18/11/2025
– Initial commercial availability begins through an Early Experience Program with Penn Highlands Healthcare and Allegheny Health Network – SAN MATEO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- PrognomiQ , a healthcare [...]
Capsa Healthcare to Showcase Integrated Central Fill Automation at ASHP Midyear 2025
18/11/2025
CANAL WINCHESTER, Ohio, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Capsa Healthcare, a leading innovator in medication management and pharmacy automation, will demonstrate its end-to-end pharmacy automation solutions at the 2025 [...]
Comprehensive Healthcare Takes Next Step Toward Expanding Access to Behavioral Healthcare in Central Washington
18/11/2025
Organization selected as one of 10 Certified Community Behavioral Health Clinic (CCBHC) pilot sites in the state YAKIMA, Wash., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Comprehensive Healthcare today announced that it was [...]
Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma
18/11/2025
Company Announcement EPKINLY plus rituximab and lenalidomide (EPKINLY + R 2 ) is the first and only bispecific-based therapy approved by the FDA for follicular lymphoma in the second-line setting In the Phase 3 EPCORE [...]
NeuroSigma Launches Next-Generation Monarch Device for Pediatric ADHD After Successful Pilot Program
18/11/2025
Company dispensed over 1,000 FDA-cleared systems in pilot phase; unveils new website and second-generation device for early 2026 launch LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. , a Los Angeles- [...]
ALX Oncology to Present at Upcoming Investor Conferences
18/11/2025
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies [...]
Synergy CHC Corp. (NASDAQ: SNYR) Adds Five New Direct Store Delivery Partners, Expanding FOCUSfactor Functional Beverage Distribution to Ten States Nationwide
18/11/2025
WESTBROOK, Maine, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced the addition of five new Direct Store [...]
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
18/11/2025
GAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) recognizes the 10-year anniversary of the U.S. Food and Drug Administration (FDA) approval of NARCAN ® (naloxone HCl) Nasal [...]
Nanox Announces Strategic Partnership with 3DR® Labs to Expand AI-Powered Imaging Solutions Across North America
18/11/2025
3DR ® Labs to Offer Nanox.AI’s FDA-Cleared Imaging Solutions to Its Network of More Than 1,800 Hospitals and Imaging Centers Across the U.S. PETACH TIKVA, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“ [...]
Catheter Precision Announces Third VIVO Installation in France
18/11/2025
First-ever multi-year agreement highlights commitment to French electrophysiology market FORT MILL, S.C., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device [...]
Annovis Announces FDA Meeting to Discuss Parkinson's Disease Dementia Program; Reaffirms FDA Alignment on Pivotal Phase 3 Alzheimer's Disease Study
18/11/2025
MALVERN, Pa., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases [...]

Pages